Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cinnarizine (75mg) Tablet
Therapeutic Category
Antihistamines, Neurology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹95/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cinagrit 75 Tablet (Cinnarizine 75 mg) is a selective calcium channel blocker and antihistamine that is widely prescribed for the symptomatic treatment of vertigo and associated symptoms like dizziness, tinnitus, nausea, and vomiting, particularly those related to Meniere's disease and travel sickness.
Key Commercial Value & Clinical Edge:
Dual Action: Cinnarizine's primary strength is its ability to inhibit calcium influx in the vestibular sensory cells, thereby reducing the excitability of the vestibular system, combined with a central antihistaminic H1 blocking action.
Broad Prescribability: It is highly valued by GPs and ENT specialists due to its efficacy in managing a wide range of balance-related disorders, which are highly prevalent in the geriatric population.
Chronic Use Potential: Vertigo and Meniere's disease often require long-term, continuous therapy, ensuring a consistent and reliable prescription flow and high customer retention.
Safety Profile: At this dose, it provides effective relief with manageable side effects, making it a reliable choice for long-term patient compliance.
Secure your exclusive Cinagrit 75 territory and capture the rapidly growing anti-vertigo market!
Common side effects may include drowsiness, dry mouth, mild stomach upset, or weight gain. Occasionally, patients may experience fatigue or allergic reactions. These effects are generally mild and subside as the body adjusts to the medication. Avoid activities requiring alertness until you know how the medicine affects you.
Cinagrit 25 Tablet is indicated for the treatment and prevention of vertigo, motion sickness, Meniere’s disease, and other vestibular disorders causing dizziness, nausea, or imbalance. It helps in enhancing stability and comfort during travel and in patients with inner ear dysfunction.
Take Cinagrit 25 Tablet as directed by your doctor, preferably after meals to avoid stomach irritation. Avoid consuming alcohol or other sedatives while on this medication, as they may enhance drowsiness. Patients with liver disease or low blood pressure should use it cautiously. Do not exceed the prescribed dose, especially when driving or operating machinery.
Store Cinagrit 25 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children and use only within the expiry period printed on the pack.
Composition : Amoxycillin (750mg) + Pantoprazole (40mg) + Clarithromycin (500mg)
Composition : Pantoprazole (20mg)
Composition : Pantoprazole (40mg) Injection
Composition : Domperidone (10mg) + Pantoprazole (40mg)
Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant
Composition : Cinitapride (3mg) + Pantoprazole (40mg)
Composition : Pantoprazole (E.C.) I.P. 40mg (E.C.) + Domperidone (I.R.) I.P. 10mg + Domperidone (S.R.) I.P. 20mg Capsules
Composition : Pantoprazole (40mg) + Itopride (150mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cinnarizine 75mg Tablet has strong demand in the anti-vertigo and vestibular disorder segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for Cinnarizine 75mg Tablet in vertigo, dizziness, and balance disorder management. Including this product helps strengthen their neuro and anti-vertigo portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Cinnarizine 75mg Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, steady demand in vertigo management, timely product availability, and professional marketing support when partnering with Cafoli Lifecare for this formulation.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Cinnarizine 75mg Tablet can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.